What Patients Can Expect During the AdaptDx Pro Test
This video outlines testing procedures for the AdaptDx Pro headset, this will help our patients understand what to expect during testing.
Patient Warning Signs
This video explains that night vision problems are the first warning sign of early stages of age-related macular degeneration. Patients experiencing difficulty seeing at night should be tested for impaired dark adaptation.
About AMD, Its Risk Factors, and First Symptoms
Trouble seeing at night is the first symptom of age-related macular degeneration (AMD), a progressive disease that affects your patients’ central vision and is the leading cause of adult blindness in the developed world. Please note this video has no sound.
Trouble Seeing At Night: More Than Just A Sign of Aging?
Typically blamed on the normal aging process, trouble seeing at night is often the first warning sign of AMD. This video educates and encourages our patients to address night vision concerns during their appointment, before disease progression compromises their central vision even further.
The Value of Early AMD Detection – Mother Daughter Story
This video captures the story of a mother with wet AMD and her daughter’s concern for her mother’s future – as well as her own risk of developing the same sight-stealing disease. By watching this video, patients will be reminded that AMD can be a multi-generational issue, with the potential for mitigation available through early detection, active treatment, and proactive management.
Impaired Dark Adaptation: The Earliest Biomarker of Age-Related Macular Degeneration
While this video was originally developed to educate doctors, patients may find it valuable to learn how subclinical AMD is affecting cell growth beneath the surface – causing changes in their vision even before drusen are visible.
AMD Brochure
Please review our brochure which plays an important role in educating our patients and their loved ones about AMD and actions they can take to obtain an early diagnosis and slow disease it’s progression.
MM-062P-ADP-Patient-Education-Brochure